BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28384635)

  • 1. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
    Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
    Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
    Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
    Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
    Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
    Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
    Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of lymphatic mapping for midgut neuroendocrine patients undergoing cytoreductive surgery.
    Wang YZ; Carrasquillo JP; McCord E; Vidrine R; Lobo ML; Zamin SA; Boudreaux P; Woltering E
    Surgery; 2014 Dec; 156(6):1498-502; discussion 1502-3. PubMed ID: 25456941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
    Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
    Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT evaluation of gastroenteric neuroendocrine tumors: relationship between ct features and the pathologic classification.
    Feng ST; Luo Y; Chan T; Peng Z; Chen J; Chen M; Li ZP
    AJR Am J Roentgenol; 2014 Sep; 203(3):W260-6. PubMed ID: 25148182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
    Zandee WT; Kamp K; van Adrichem RC; Feelders RA; de Herder WW
    Eur J Endocrinol; 2016 Nov; 175(5):361-6. PubMed ID: 27491374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic imaging of gastrointestinal neuroendocrine tumours (GI-NETs): relationship between MDCT features and 2010 WHO classification.
    Grazzini G; Danti G; Cozzi D; Lanzetta MM; Addeo G; Falchini M; Masserelli A; Pradella S; Miele V
    Radiol Med; 2019 Feb; 124(2):94-102. PubMed ID: 30255371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
    Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
    Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
    de Mestier L; Savagner F; Brixi H; Do Cao C; Dominguez-Tinajero S; Roquin G; Goichot B; Hentic O; Dubreuil O; Hautefeuille V; Walter T; Cadiot G
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1673-e1682. PubMed ID: 33382891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.
    Kimbrough CW; Beal EW; Dillhoff ME; Schmidt CR; Pawlik TM; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Crown A; Abbott DE; Fisher AV; Fields RC; Krasnick BA; Idrees K; Marincola-Smith P; Cho CS; Beems M; Maithel SK; Cloyd JM
    Surgery; 2019 Mar; 165(3):657-663. PubMed ID: 30377003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological features and metastatic patterns of thymic neuroendocrine tumours.
    Araki T; Sholl LM; Hatabu H; Nishino M
    Clin Radiol; 2018 May; 73(5):479-484. PubMed ID: 29310810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts.
    Bonds M; Rocha FG
    Surg Clin North Am; 2020 Jun; 100(3):635-648. PubMed ID: 32402306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.